Remove 2023 Remove FDA Approval Remove Packaging Remove Pharmacokinetics
article thumbnail

ChEMBL 34 is out!

The ChEMBL-og

71 out of the 882 newly added EMA drugs are only authorised by EMA, rather than from other regulatory bodies e.g. FDA. Zimmermann Lab Biotransformation data Dec 2023 (src_id = 69): 271 compounds have been tested for biotransformation in 68 bacterial species and 28 bacterial communities. University of Dundee: T. University of Dundee: T.

article thumbnail

FDA Accepts for Review Pfizer’s Supplemental Application for ABRILADA™ (adalimumab-afzb) Interchangeability

The Pharma Data

The study met its primary goal by demonstrating pharmacokinetic equivalence in patients who switched multiple times between treatment with the two medicines. The FDA approval was based on the review of a comprehensive data package which demonstrated biosimilarity of ABRILADA to the reference product.

article thumbnail

Release of ChEMBL 33

The ChEMBL-og

Cardiff Schistosomiasis Dataset 2023 (src_id = 64): A library of 80 compounds were tested in vitro on different life cycle stages of the parasite Schistosoma mansoni. Data set retrieved from COCONUT team on 05/05/2023. Have fun playing around with ChEMBL 33 over the summer and please send feedback via chembl-help@ebi.ac.uk.